Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from Pfizer

Two years into the pandemic, unequal access to COVID-19 treatments threatens the global recovery

It’s now two years since the World Health Organization began calling the COVID-19 outbreak a pandemic.

The Conversation

Weekly Must-Read: China Meheco Confirms Pfizer Talks on Selling Paxlovid in China

State-owned drugmaker’s shares surge by 10% limit on four straight days in Shanghai, though its role may be limited to distribution logistics

Caixin Global

Which companies aren’t exiting Russia? Big pharma

Even as the war in Ukraine has prompted an exodus of international companies — from fast-food chains and oil producers to luxury retailers — from Russia, U.S. and global drug companies said they would continue manufacturing and selling their products there.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

George Christensen says 'elites' have suddenly started hiding vaccinated death statistics. Here's why that's wrong

Coalition backbencher George Christensen took to Facebook this week to claim the government has suddenly stopped reporting vaccinated death statistics. Is that correct?

ABC News

Africa CDC signs MOU with Pfizer to supply COVID-19 pills

The confirmation from Africa’s top public health agency comes within days of Modena and J&J announcing deals in Africa.

Al Jazeera

Ukraine publishes list of 50 global brands that are continuing to operate in Russia

Burger King suspends operations in Russia after being named on list alongside Pfizer, Johnson and Johnson and Samsung Electronics

The Independent UK

Vacunados con J&J, reforzados con ARNm, y pensando en la tercera dosis

Sí, todos estamos agotados por la pandemia de covid. Desconcertados por los constantes cambios en la ciencia y en las directrices. Preocupados por la sucesión de nuevas y temibles variantes, cada una con su propio nombre, como los huracanes.

Tribune News Service

Read news from The Economist, FT, and more,
with one subscription

Pfizer studying COVID pill Paxlovid in children age 6 and older

Pfizer Inc. said it launched a study of its oral Covid-19 treatment among children age 6 and up who have been infected by the virus and are at risk of progressing to severe disease.

Tribune News Service

Pfizer's Paxlovid Becomes First Oral COVID-19 Therapy To Be Evaluated In Pediatric Clinical Study

Pfizer Inc (NYSE: PFE) has initiated a Phase 2/3 EPIC-PEDS trial to evaluate Paxlovid (nirmatrelvir and ritonavir tablets)

Benzinga

The Daily Biotech Pulse: Pfizer Begins Late-Stage Pediatric COVID Pill Study, Midatech And J&J Unit Expand R&D Collaboration, AbbVie-Alvotech Settle Humira Dispute

Here's a roundup of top developments in the biotech space over the last 24 hours.

Benzinga

Pfizer CEO claims Jared Kushner wanted to reroute vaccines from Canada and Latin America to US

‘Jared didn’t budge. In his mind, America was coming first no matter what,’ Albert Bourla writes

The Independent UK

No, vaccines in kids aren't failing

More research is needed, but likely omicron is to blame and not an overly low dosage for children

Salon

Looking At Pfizer's Recent Whale Trades

A whale with a lot of money to spend has taken a noticeably bullish stance on Pfizer. Looking at options history for Pfizer (NYSE:PFE) we detected 27 strange trades.

Benzinga

South Africa risks destroying 100,000 vaccine doses by end-March due to slow uptake

About 100,000 doses of Pfizer's COVID-19 vaccine are at risk of being destroyed by the end of this month due to slow uptake by citizens, South African health authorities said on Friday.

Reuters

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Pfizer Commits 10M Courses Of COVID-19 Oral Antiviral To Developing Countries: Reuters

Pfizer Inc (NYSE:PFE) is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries in 2022, reports Reuters citing an official with the Global Fund. The Fund's head of strategy for policy, Harley Feldbaum, said Pfizer had committed at least that many…

The Independent UK

EU clears Moderna shot for young kids, Pfizer boosters

The European Medicines Agency said it has authorized Moderna’s coronavirus vaccine for children aged six to 11, in addition to recommending booster shots of Pfizer’s vaccine for those aged 12 and over

Benzinga

Why Pfizer Shares Are Trading Higher Today

Pfizer Inc (NYSE: PFE) is trading higher Wednesday after the company received Breakthrough Therapy Designation from the U.S. Food and Drug Administration for PF-06482077, or RSVpreF, the company's respiratory syncytial virus vaccine candidate.

Newsroom.co.nz

Vaccine mandates: Government to fight fire with science in High Court

Leaders of a group challenging their vaccine mandates this week include a GP suspended for distributing misinformation, and a Northland anti-abortion activist

Get all your
news in one place.

100’s of premium titles.
One news app.

Reuters

Pfizer to provide 10 million courses of COVID pill to developing countries -the Global Fund

Pfizer Inc is expected to provide around 10 million courses of its highly effective COVID-19 antiviral treatment Paxlovid to low- and middle-income countries this year, according to an official with the Global Fund, a healthcare NGO working to buy the pills from the drugmaker.

The Independent UK

EXPLAINER: Why Pfizer needs time to make COVID-19 treatment

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets

Daily Record

Pfizer Covid vaccine less effective in kids aged between five and 11, study finds

Children in this age group are set to receive the Covid jab from later this month.

The Independent UK

Pfizer shots protect kids from severe COVID even in omicron

A new government report shows Pfizer’s COVID-19 vaccine gave children 5 and older strong protection against hospitalization and death even during the omicron surge

Benzinga

Pfizer/BioNTech's COVID-19 Vaccine Mere 12% Effective In Kids 5-11 Years, New York Study Shows

According to a published study, Pfizer Inc (NYSE: PFE) and BioNTech SE's (NASDAQ: BNTX) two-dose COVID-19 vaccine provided very little protection for children aged 5 to 11 years during the wave of o

Benzinga

Pfizer's Clostridioides Difficile Vaccine Fails To Prevent C. Difficile Infection

Pfizer Inc (NYSE: PFE) announced data from the CLOVER Phase 3 trial evaluating Clostridioides difficile vaccine candidate to prevent C. difficile infection (CDI).

Salon

COVID vax: Pregnant women left behind

Clinical trials of COVID vaccines excluded pregnant people, which left many wondering whether to get vaccinated

1 … 62 63 64 65

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

World Health Organization

Read news from The Economist, FT, and more,
with one subscription

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.